AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Corticosteroids for Post-Extubation Dysphagia

RecruitingPhase 2Ages 18 Years - anyAllUniversity of Colorado, Denver
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a placebo-controlled, double-blind randomized trial of a short course of intravenous corticosteroids for Acute Respiratory Failure Survivors with Fiberoptic Endoscopic Evaluation of Swallowing (FEES) documented laryngeal edema. Study was leveraged using the existing R01 grant infrastructure COMIRB # 21-3873, study design, and research methods. Patients for the study proposed will have already been enrolled in the R01 longitudinal cohort study. The sites to perform this study include Colorado, BU, Yale, Tufts, and Stanford. Those R01-enrolled patients with laryngeal edema on their initial FEES examination: defined as the revised Patterson edema score greater than zero, will be approached for enrollment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Participant enrolled in primary study COMIRB #21-3873/ NCT # 05108896 * Laryngeal edema identified on participants primary study Fiberoptic Endoscopic Evaluation of Swallowing (FEES) as defined as a revised Patterson edema score greater than zero * Admission to an ICU during their hospitalization * Mechanical ventilation with an endotracheal tube for greater than 48 hours. * Extubation except for compassionate extubation or transition to end-of-life care. Exclusion Criteria: * Patient or provider refusal * Contraindication or corticosteroids defined as an allergic reaction (extremely rate) or taking other immunosuppressive medications. * Chronic treatment with corticosteroids (\>= 40 mg Prednisone/day, \>=32 Methylprednisolone/day) * Contraindication to enteral/oral nutrition administration. * Pre-existing history of dysphagia or aspiration. * Pre-existing or acute primary central or peripheral neuromuscular disorder. * Presence of a chronic tracheostomy (present prior to ICU admission). * Pre-existing head and neck cancer or surgery. * Coagulopathy resulting in uncontrolled nasal or pharyngeal bleeding. * Delirium as assessed by CAM-ICU * Inability to obtain informed consent from patient or an appropriate surrogate. * Age \<18 years.
๐Ÿ’Š

What it tests

  • Methylprednisolone
  • Normal Saline
๐Ÿ“

Where

1 site
University of Colorado
Aurora, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy